| HCV 
                          - Liver Cirrhosis   Do 
                          IL28B Gene Variations Affect Liver 
                          Disease Progression in People with Hepatitis 
                          C? 11-19-2010
 
 Sustained Response 
                          to Antiviral Therapy Prevents Esophageal Varices in 
                          Hepatitis C Patients with Cirrhosis
 7-05-2010
 
 Treating Hepatitis 
                          C in People with Compensated 
                          Cirrhosis Is Most Cost-effective Approach
 7-02-2010
 
 Rifaximin 
                          Reduces Encephalopathy Recurrence, Improves Quality 
                          of Life in People with Liver 
                          Cirrhosis
 5-28-2010
 
 Pegylated 
                          Interferon plus Ribavirin Works as Well in HIV/HCV Coinfected 
                          Patients with Cirrhosis
 5-28-2010
 
 Measurable Neurocognitive 
                          Impairment Persists after Episodes of Hepatic Encephalopathy 
                          in People with Liver Cirrhosis
 5-11-2010
 
 Interferon-based Therapy 
                          Less Effective for Hepatitis C Patients with Advanced 
                          Liver Fibrosis or Cirrhosis
 4-9-2010
 
 Sustained 
                          Virological Response to Interferon-based Therapy Slows 
                          Progression of Liver Cirrhosis 
                          in Hepatitis C Patients
 11-24-09
 
 Coffee 
                          Slows Progression of Liver Disease in Hepatitis C Patients 
                          with Advanced Fibrosis or Cirrhosis
 10-23-09
 
 Hepatitis 
                          C May Not Increase Mortality among Patients Who Are 
                          Not Coinfected, Do Not Drink Heavily, and Do Not Have 
                          Cirrhosis 9-25-09
 
 Bone Loss and Vitamin D 
                          Deficiency Are Common among People with Liver 
                          Cirrhosis
 9-01-2009
 
 Diets High in Protein and 
                          Cholesterol May Increase Risk of Liver 
                          Cirrhosis and Cancer, while Carbohydrates 
                          May Be Protective
 8-7-2009
 
 Pegylated 
                          Interferon alfa-2b (PegIntron) Maintenance Monotherapy 
                          May Reduce Esophageal Varices in Hepatitis C Patients 
                          with Cirrhosis
 5-5-09
 
 Liver 
                          Disease Progression and Treatment Response 
                          in Latino and Asian Patients with Chronic Hepatitis 
                          C
 12-12-08
 
 Selected 
                          Hepatitis C Patients with Decompensated 
                          Cirrhosis Can Benefit from Interferon-based 
                          Therapy prior to Liver Transplantation
 6-10-08
 
 Natural 
                          History of HCV-Related Cirrhosis 
                          after Liver Transplantation
 5-08-08
 
 Pegylated 
                          Interferon plus Ribavirin for Patients with HCV-related 
                          Liver Cirrhosis
 3-11-08
 Non-Invasive 
                          Ways to Assess Liver Disease: 
                          Studies 
                          Test Alternatives to Liver Biopsy 2-05-08
 
      
                           
                           
                            |